All-cause and immune checkpoint inhibitor–associated acute kidney injury in immune checkpoint inhibitor users: a meta-analysis of occurrence rate, risk factors and …
ABSTRACT Background Immune checkpoint inhibitors (ICIs) have been associated with
acute kidney injury (AKI). However, the occurrence rate of ICI-related AKI has not been …
acute kidney injury (AKI). However, the occurrence rate of ICI-related AKI has not been …
Associations between immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitor therapy
Y Inoue, N Inui - Internal Medicine, 2024 - jstage.jst.go.jp
The number of patients with cancer qualifying for treatment with immune checkpoint
inhibitors (ICIs) continues to increase, and a clearer understanding of the mechanisms …
inhibitors (ICIs) continues to increase, and a clearer understanding of the mechanisms …
Acute kidney injury in cancer patients receiving anti-vascular endothelial growth factor monoclonal antibody vs. immune checkpoint inhibitors: a retrospective real …
J Zhu, X Ding, J Zhang, B Chen, X You, X Chen… - BMC cancer, 2024 - Springer
Background Anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF) or
immune checkpoint inhibitors (ICIs) combined with chemotherapy are commonly …
immune checkpoint inhibitors (ICIs) combined with chemotherapy are commonly …
Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience
Background Immune checkpoint inhibitor (ICI)-associated acute interstitial nephritis (AIN) is
a recognized complication of immunotherapy (IO), but literature on its management and …
a recognized complication of immunotherapy (IO), but literature on its management and …
PD-1/PD-L1 Inhibitors for the Treatment of Lung Cancer
Y Patil, B Dakhni, S Kolhatkar - Immunotherapy Against Lung Cancer …, 2024 - Springer
Immune checkpoint inhibitors (ICIs) have gained significant attention and traction in the last
few years in the treatment of lung cancer and cancers in general. The primary driver of this …
few years in the treatment of lung cancer and cancers in general. The primary driver of this …
Prediction models and prognostic analysis of immune-related acute kidney injury in lung cancer patients
S Qian, N Xu, Y Qu, R Zhu, M Zhang, K Chen, J Wang… - 2024 - researchsquare.com
Background: Immune checkpoint inhibitors (ICIs) are extensively utilized in lung cancer
patients, with documented instances of ICIs-associated acute kidney injury (ICIs-AKI). This …
patients, with documented instances of ICIs-associated acute kidney injury (ICIs-AKI). This …